# Comparative Research of Alzheimer's Disease Drugs

> **NCT01362686** · NA · TERMINATED · sponsor: **Indiana University** · enrollment: 200 (actual)

## Conditions studied

- Dementia
- Alzheimer's Disease

## Interventions

- **DRUG:** Donepezil
- **DRUG:** Galantamine
- **DRUG:** Rivastigmine

## Key facts

- **NCT ID:** NCT01362686
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-04
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 200 (ACTUAL)
- **Why stopped:** Low study accrual caused the study to be ended early.
- **Last updated:** 2017-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01362686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01362686, "Comparative Research of Alzheimer's Disease Drugs". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01362686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*